Singapore markets open in 33 minutes
  • Straits Times Index

    3,173.93
    -10.61 (-0.33%)
     
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • Dow

    33,745.40
    -55.20 (-0.16%)
     
  • Nasdaq

    13,850.00
    -50.19 (-0.36%)
     
  • BTC-USD

    60,217.88
    +132.04 (+0.22%)
     
  • CMC Crypto 200

    1,291.27
    -3.32 (-0.26%)
     
  • FTSE 100

    6,889.12
    -26.63 (-0.39%)
     
  • Gold

    1,730.60
    -2.10 (-0.12%)
     
  • Crude Oil

    59.82
    +0.12 (+0.20%)
     
  • 10-Yr Bond

    1.6750
    +0.0090 (+0.54%)
     
  • Nikkei

    29,586.00
    +47.27 (+0.16%)
     
  • Hang Seng

    28,453.28
    -245.52 (-0.86%)
     
  • FTSE Bursa Malaysia

    1,608.42
    -3.83 (-0.24%)
     
  • Jakarta Composite Index

    5,948.57
    -121.64 (-2.00%)
     
  • PSE Index

    6,518.64
    -26.53 (-0.41%)
     

Global Metered Dose Inhaler Devices Pipeline Assessment Report 2020 - ResearchAndMarkets.com

·3-min read

The "Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

"Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Metered Dose Inhaler Devices delivers a specific amount of medication to lungs and GI tract. It is mostly used by asthma and COPD patients.

Scope

  • Extensive coverage of the Metered Dose Inhaler Devices under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of Metered Dose Inhaler Devices under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Metered Dose Inhaler Devices Overview

3 Products under Development

3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development

3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory

3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path

3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date

3.5 Metered Dose Inhaler Devices - Ongoing Clinical Trials

4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies

4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development

4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development

5 Metered Dose Inhaler Devices Companies and Product Overview

5.1 Adamis Pharmaceuticals Corp Company Overview

5.2 Aeropharm GmbH Company Overview

5.3 Aerophase Inc Company Overview

5.4 AstraZeneca Plc Company Overview

5.5 Bespak Europe Ltd Company Overview

5.6 Circassia Group Plc Company Overview

5.7 Globe Medical Tech Inc (Inactive) Company Overview

5.8 GoFire Inc Company Overview

5.9 Lab Automate Technologies Inc Company Overview

5.10 Lupin Pharmaceuticals Inc Company Overview

5.11 Medicom Innovation Partner a/s Company Overview

5.12 Nemera La Verpilliere Company Overview

5.13 Pearl Therapeutics Inc Company Overview

5.14 Reciprocal Labs Corp Company Overview

5.15 Rensselaer Polytechnic Institute Company Overview

5.16 Vectura Group Plc Company Overview

5.17 Verona Pharma Plc Company Overview

6 Metered Dose Inhaler Devices- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/md0zrb

View source version on businesswire.com: https://www.businesswire.com/news/home/20210408005670/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900